BMJ1d
LB0003 A Randomized Controlled Study of Laquinimod in Active Lupus Nephritis Patients in Combination with Standard of Care
Background Laquinimod (LAQ) is a novel oral immunomodulator in development for the treatment of Lupus Nephritis (LN). LAQ has an immune modulatory effect on antigen presenting cells directing T cells ...
BMJ13d
Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease
Chimeric antigen receptors (CARs) are synthetic proteins designed to direct an immune response toward a specific target and have been used in immunotherapeutic applications through the adoptive ...
BMJ2d
POS1193 COVID-19 IN PATIENTS WITH GIANT CELL ARTERITIS
Background Patients with giant cell arteritis (GCA) represent a fragile population with an increased infection risk. In a recent study 1 older age, a higher number of comorbidities, higher disease ...
BMJ8d
bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease
Correspondence to Professor Norbert Blank, Heidelberg University Hospital Department of Hematology Oncology and Rheumatology, Heidelberg, Baden-Württemberg, Germany; ...
BMJ12d
Validation and incorporation of digital entheses into a preliminary GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS) in psoriatic arthritis
Objectives The main objective was to generate a GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS) in psoriatic arthritis and to test its reliability. To this end, we assessed the validity, ...
BMJ8d
Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs
Correspondence to Dr Jörg H W Distler, Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, ...
BMJ4d
Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21
Correspondence to Mr Xinyu Yang, Xinyu Yang, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China; cyrillyoung{at}163.com and Dr ...
BMJ12d
ANCA antibodies in Graves' disease
1 Rheumatology Section, Hospital Universitari Germans Trias i Pujol, Crta del Canyet s/n Badalona, 08916 Barcelona, Spain; aolive@ns.hugtip.scs.es 2 Immunology Section, Hospital Universitari Germans ...
BMJ8d
Association between age and knee structural change: a cross sectional MRI based study
Objective: To describe the associations between age, knee cartilage morphology, and bone size in adults. Methods: A cross sectional convenience sample of 372 male and female subjects (mean age 45 ...
BMJ4d
AB0958 LOW-ENERGY PULSED ELECTROMAGNETIC FIELD THERAPY REDUCES PAIN IN FIBROMYALGIA: A RANDOMIZED SINGLE-BLIND CONTROLLED PILOT STUDY.
Background: Fibromyalgia is a clinical condition characterized by diffuse chronic muscle-skeletal pain, fatigue, sleep/mood disorders and muscular stiffness. The pathogenesis of fibromyalgia remains ...
BMJ14d
Interleukin 27 attenuates collagen-induced arthritis
Department of Physiology, Yong Loo Lin School of Medicine, University of Singapore, Singapore Professor F Y Liew, Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre ...
BMJ10d
Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial
Correspondence to Professor Margreet Kloppenburg, Department of Rheumatology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; g.kloppenburg{at}lumc.nl Objective Hand osteoarthritis ...